Cardio Diagnostics Holdings, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Cardio Diagnostics Holdings, Inc. (CDIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 452.85 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 441.43K shares, a 8.56% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 406.62K shares, a 0.83% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 410.04K shares, a 95.74% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 9.61M shares, a 4358.17% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 428.61K shares, a 6.07% increase from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 404.10K shares, a 96.13% decline from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 10.44M shares, a 7.46% increase from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.71M shares, a 8352.73% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 452.85K shares 10-Q · filed 2026-08-07 | |||||||
| 2026-03-31 | 441.43K shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 428.61K shares 10-K · filed 2026-03-13 | |||||||
| 2025-09-30 | 419.39K shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 413.15K shares 10-Q · filed 2026-08-07 | |||||||
| 2025-03-31 | 406.62K shares 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | 404.10K shares 10-K · filed 2026-03-13 | 12.12M shares 10-K · filed 2025-03-20 | ||||||
| 2024-09-30 | 413.26K shares 10-Q · filed 2025-11-12 | 12.40M shares 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | 410.85K shares 10-Q · filed 2025-08-14 | 12.33M shares 10-Q · filed 2024-08-12 | ||||||
| 2024-03-31 | 410.04K shares 10-Q · filed 2025-05-15 | 12.30M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 10.44M shares 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | 10.44M shares 10-Q · filed 2024-11-13 | |||||||
| 2023-06-30 | 10.44M shares 10-Q · filed 2024-08-12 | |||||||
| 2023-03-31 | 9.61M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 9.71M shares 10-K · filed 2024-04-01 | 11.21M shares 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | 9.71M shares 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | 3.57M shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 215.65K shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 114.92K shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |